Why Ozempic Might Not Be the Miracle You Think | Dr. Vanita Rahman

GLP-1 weight loss drugs like Ozempic and Wegovy are being hailed as game-changers, but are they really safe, effective, or sustainable?

 

Dr. Vanita Rahman joins Chuck Carroll to unpack the data behind these billion-dollar drugs, highlighting alarming side effects, minimal long-term benefits, and industry conflicts of interest. With 129 million Americans eligible and a price tag of $1,600 per month, the stakes are massive.

 

This episode explores a better way forward—using food as medicine and empowering people with knowledge, not prescriptions.

 

Plus, Chuck opens up about his own weight loss surgery—and the one thing he wishes he knew beforehand.

— — SHOW LINKS — —

Ozempic Risks and Letter

https://bit.ly/OzempicRisk

— — EVENTS — —

Exam Room LIVE: Longevity and Muscle Building

GreenFare Organic Restaurant

Where: Herndon, VA

When: May 28, 2025

Tix: https://bit.ly/ERTixGFMay2025

— — —

NHA Conference

Where: Cleveland, OH

When: June 26-29, 2025

Tix & Speakers: https://bit.ly/NHAtix2025

— — —

International Conference on Nutrition in Medicine

Where: Washington, DC

When: August 14-16, 2025

Tix & Speakers: https://www.pcrm.org/icnm

— — BECOME AN EXAM ROOM VIP — —

Sign up: https://www.pcrm.org/examroomvip

— — THIS IS US — —

The Exam Room Podcast

Instagram: https://www.instagram.com/theexamroompodcast

— — —

Chuck Carroll

Instagram: https://www.instagram.com/ChuckCarrollWLC

Facebook: https://www.facebook.com/ChuckCarrollWLC

X: https://www.twitter.com/ChuckCarrollWLC

— — —

Physicians Committee

Instagram: https://www.instagram.com/physicianscommittee

Facebook: https://www.facebook.com/PCRM.org

X: https://www.twitter.com/pcrm

YouTube: https://www.youtube.com/user/PCRM

Jobs: https://www.pcrm.org/careers

— — SUBSCRIBE & S